Identifying market risk for substandard and falsified medicines

We have developed a framework to guide country-specific, system-wide analysis. This can flag risks and pinpoint specific actions to protect medicine quality.

We have developed a framework to guide country-specific, system-wide analysis. This can flag risks and pinpoint specific actions to protect medicine quality.

Identifying market risk for substandard and falsified medicines - NCBI

The fault lies in defective procurement policies that do not properly factor in quality criteria and the reluctance of governments to provide adequate financing ...

[PDF] Identifying market risk for substandard and falsified medicines ...

Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania.

Supporting data for: Identifying market risk for substandard and ...

Supporting data for: Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, ...

Supporting data for: Identifying market risk for substandard and ...

Supporting data for: Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in ...

Substandard and falsified medical products and informa

Online informal markets were also identified in some middle-income countries and primarily included illegitimate pharmacies selling antibiotics, ...

Identifying market risk for substandard and falsified medicines

We have developed a framework to guide country-specific, system-wide analysis. This can flag risks and pinpoint specific actions to protect medicine quality, ...

Identifying market risk for substandard and falsified medicines

Supporting data for: Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in ...

Identifying substandard and falsified medical products: a market risk...

Substandard and falsified medicines undermine health systems. We sought to unravel the political and economic factors which drive the production of these ...

Substandard and Falsified Medicines: Proposed Methods for Case ...

We propose adding indicators of the market factors shown in Tables 2 and 3 to increase the specificity of existing risk-based sampling and to ...

Identifying market risk for substandard and falsified medicines: an ...

Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania.

Identifying market risk for substandard and falsified medicines: an ...

Description. This dataset contains supporting data for a study of the political and economic drivers of substandard and falsified medicines in ...

Substandard and falsified medical products

Identifying a substandard or falsified medical product · examining the packaging for condition, spelling mistakes or grammatical errors; ...

Substandard and falsified medical products: bibliometric analysis ...

Substandard and falsified (SF) medical products are a global public health threat. The presence and spread of SF drugs negatively affect (1) ...

Falsified medicines | IFPMA

The expansion and growing sophistication of the methods used by criminals who manufacture, distribute, and sell substandard and falsified medicinal products ...

Responding to the surge of substandard and falsified health ... - USP

Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China,. Indonesia ...

Global perspective of the risks of falsified and counterfeit medicines

Counterfeit pharmaceuticals, originating from within the region or imported from other sources, can enter both domestic and international markets [113,114]. In ...

Full article: Inferring sources of substandard and falsified products in ...

Substandard and falsified pharmaceuticals, prevalent in low- and middle-income countries, substantially increase levels of morbidity, mortality and drug ...

Fighting the fakes: tackling substandard and falsified medicines

WHO estimates that 1 in 10 medicines circulating in low-income and middle-income countries (LMICs) is either substandard or falsified. The ratio ...